Showing results (301-310 of 406) with videos related to
Sort By:
Pageof 41
Equine Veterinary Journal|April 23, 2014
A diagnostic evaluation of real-time PCR, fluorescent antibody and microscopic agglutination tests in cases of equine leptospiral abortionE Erol, C B Jackson, M Steinman, et al.Case Reports in Genetics|October 29, 2025
RAPSN-Associated Congenital Myasthenic Syndrome due to Biallelic Single Nucleotide Variants at the Same PositionLaura Keehan, Jennefer N Carter, Elijah Kravets, et al.Research Square|August 26, 2024
EditABLE: A Simple Web Application for Designing Genome Editing ExperimentsDemetrios S Maxim, David Wei Wu, Najani Shanee Johnson, et al.The Journal of Biological Chemistry|November 24, 1999
Xanthine phosphoribosyltransferase from Leishmania donovani. Molecular cloning, biochemical characterization, and genetic analysisA Jardim, S E Bergeson, S Shih, et al.The Quarterly Journal of Medicine|January 1, 1981
The congenital "magnesium-losing kidney". Report of two patientsR A Evans, J N Carter, C R George, et al.Eneuro|June 15, 2017
Wortmannin Attenuates Seizure-Induced Hyperactive PI3K/Akt/mTOR Signaling, Impaired Memory, and Spine Dysmorphology in RatsAngela N Carter, Heather A Born, Amber T Levine, et al.International Journal of Clinical Pharmacology and Therapeutics|August 27, 2005
A bioequivalence study of citalopram based on quantification by high-performance liquid chromatography coupled to electrospray tandem mass spectrometryG Duarte Mendes, N Carter do Carmo Borges, A dos Santos Pereira, et al.Journal of Interpersonal Violence|September 6, 2021
The Dynamics of Interpersonal Relationships: Understanding Power and Control Tactics Among College StudentsMichelle L Munro-Kramer, Lauren M Skidmore, Lindsay M Cannon, et al.Veterinary Microbiology|March 14, 2012
An investigation of a recent outbreak of nocardioform placentitis caused abortions in horsesErdal Erol, Stephen F Sells, Neil M Williams, et al.International Immunology|August 30, 2001
Reversal of experimental allergic encephalomyelitis with non-mitogenic, non-depleting anti-CD3 mAb therapy with a preferential effect on T(h)1 cells that is augmented by IL-4G T Tran, N Carter, X Y He, et al.Pageof 41